PRICE T ROWE GROUP INC TROW
Nasdaq · XNAS · stock · Investment Advice
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
54.8%
Dividend payout · moderate
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $7.3B | $2.1B | — | $1.5B | $11.0B |
| 2024 | $7.1B | $2.1B | — | $1.3B | $10.5B |
| 2023 | $6.5B | $1.8B | — | $911.2M | $9.7B |
| 2022 | $6.5B | $1.6B | — | $2.1B | $9.0B |
| 2021 | $7.7B | $3.1B | — | $3.2B | $9.3B |
| 2020 | $6.2B | $2.4B | — | $1.7B | $7.7B |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0001113169 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.